WordNet

means of maintenance of a family or group
the unauthorized interference in a legal action by a person having no interest in it (as by helping one party with money or otherwise to continue the action) so as to obstruct justice or promote unnecessary litigation or unsettle the peace of the community; "unlike champerty, criminal maintenance does not necessarily involve personal profit" (同)criminal maintenance
a drug that lowers the bodys normal immune response (同)immunosuppressor, immunosuppressive_drug, immunosuppressive, immune suppressant drug

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人の腎移植における免疫抑制維持療法 maintenance immunosuppressive therapy in renal transplantation in adults
2. 心臓移植における免疫抑制療法の導入および維持 induction and maintenance of immunosuppressive therapy in cardiac transplantation
3. 腎移植後のステロイド投与の中止または回避 withdrawal or avoidance of glucocorticoids after renal transplantation
4. 実質臓器移植レシピエントにおける感染 infection in the solid organ transplant recipient
5. リウマチ性疾患に用いる免疫抑制剤と従来型の（非生物学的製剤の）疾患修飾性抗リウマチ薬の概要 overview of immunosuppressive and conventional non biologic disease modifying drugs in the rheumatic diseases

Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus.

Mandelbrot DA1, Alberú J2, Barama A3, Marder BA4, Silva HT Jr5, Flechner SM6, Flynn A7, Healy C7, Li H7, Tortorici MA7, Schulman SL7.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.Am J Transplant.2015 Dec;15(12):3174-84. doi: 10.1111/ajt.13384. Epub 2015 Jul 14.
This prospective, randomized, double-blind, placebo-controlled study evaluated the effects of ramipril on urinary protein excretion in renal transplant patients treated with sirolimus following conversion from a calcineurin inhibitor. Patients received ramipril or placebo for up to 6 weeks before co
PMID 26176342

Tacrolimus for prevention and treatment of rejection of solid organ transplants.

Scalea JR1, Levi ST2, Ally W3, Brayman KL2,4.
Expert review of clinical immunology.Expert Rev Clin Immunol.2015 Nov 20. [Epub ahead of print]
Since its introduction to the antirejection armamentarium in 1994, tacrolimus has become the workhorse of transplant professionals for avoidance of solid organ transplant rejection. Not only does tacrolimus have potent immunosuppressive qualities which prevent rejection, but dosing is straight forwa
PMID 26588770

Ravani P1, Bonanni A2, Rossi R2, Caridi G2, Ghiggeri GM3.
Clinical journal of the American Society of Nephrology : CJASN.Clin J Am Soc Nephrol.2015 Nov 19. pii: CJN.08500815. [Epub ahead of print]
Rituximab, a chimeric anti-CD20 monoclonal antibody originally licensed for lymphoma, is emerging as a novel steroid-sparing agent for idiopathic nephrotic syndrome in children. The potential use of anti-CD20 monoclonal antibodies in idiopathic nephrotic syndrome has contributed to shifting the view
PMID 26585985